![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 38/00 | |
G01N 33/573 | |||
C12N 9/00 | |||
C12Q 1/68 | |||
C12N 15/113 |
(11) | Number of the document | 2408905 |
(13) | Kind of document | T |
(96) | European patent application number | 10753998.3 |
Date of filing the European patent application | 2010-03-16 | |
(97) | Date of publication of the European application | 2012-01-25 |
(45) | Date of publication and mention of the grant of the patent | 2017-05-10 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2010/027525 |
Date | 2010-03-16 |
(87) | Number | WO 2010/107825 |
Date | 2010-09-23 |
(30) | Number | Date | Country code |
160630 P | 2009-03-16 | US | |
239747 P | 2009-09-03 | US |
(72) |
ZHOU, Jie, CN
LAU, Ching Fun, CN
XU, Zhiwen, CN
LO, Wing Sze, CN
PIEHL, Kristi Helen, US
GREENE, Leslie Ann, US
|
(73) |
Pangu Biopharma Limited,
Edinburgh Tower, 18/F The Landmark 15 Queen`s Road Central, Hong Kong,
CN
aTyr Pharma, Inc., 3565 General Atomics Court, Suite 103, San Diego CA 92121, US |
(54) | COMPOSITIONS AND METHODS COMPRISING HISTIDYL-TRNA SYNTHETASE SPLICE VARIANTS HAVING NON-CANONICAL BIOLOGICAL ACTIVITIES |
COMPOSITIONS AND METHODS COMPRISING HISTIDYL-TRNA SYNTHETASE SPLICE VARIANTS HAVING NON-CANONICAL BIOLOGICAL ACTIVITIES |